Evolent Health, Inc. EVH Restricted Cash and Investments
Restricted Cash and Investments at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashAndInvestmentsNoncurrent.
The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evolent Health, Inc.'s restricted cash and investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Evolent Health, Inc.'s restricted cash and investments?
- Evolent Health, Inc. (EVH) reported restricted cash and investments of $2.74M in Q1 2026.
- How has Evolent Health, Inc.'s restricted cash and investments changed year-over-year?
- Evolent Health, Inc.'s restricted cash and investments decreased by 81.8% year-over-year, from $15.06M to $2.74M.
- What is the long-term trend for Evolent Health, Inc.'s restricted cash and investments?
- Over 5 years (2020 to 2025), Evolent Health, Inc.'s restricted cash and investments has grown at a -16.5% compound annual growth rate (CAGR), from $6.65M to $2.71M.